Výsledky vyhledávání - "Geraldine Maro"

Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis

Autor: Vincent Rives, Patrick Sommerer, Geraldine Maro, Sarah Mangles, Cedric Hermans, Renato Marino, Giuseppe Malcangi, Catherine Lambert

Publikováno v: Advances in therapy, Vol. 37, no.6, p. 2988-2998 (2020)
Advances in Therapy

Introduction Despite the well-documented benefits of prophylaxis, treatment burden is still a barrier to adherence in patients with haemophilia. An extended half-life fusion protein linking recombinant FIX (rFIX) with human albumin (rIX-FP) has been

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2df5d71e09cc1a1147eb6ead35d75481
https://doi.org/10.1007/s12325-020-01300-6

Zobrazit plný text záznamu

Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII‐SingleChain and other common rFVIII products in Germany

Autor: Patrick Sommerer, Geraldine Maro, Songkai Yan, Martin Olivieri

Publikováno v: European Journal of Haematology

Objective To evaluate real‐world outcomes with rVIII‐SingleChain and other commonly used recombinant FVIII (rFVIII) products. Methods Hemophilia treatment centers in Germany (n = 21) contributed patient chart data. Inclusion criteria were prophyl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a86378789ce5db38661f1ccae4bb4a5
https://doi.org/10.1111/ejh.13378

Zobrazit plný text záznamu

Plný text ve formátu HTML

Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy

Autor: Songkai Yan, Andreas Tiede, Johannes Oldenburg, Geraldine Maro, Girishanthy Krishnarajah

Publikováno v: Current medical research and opinion. 36(1)

Objective: An extended half-life factor IX (FIX) fusion protein linking recombinant FIX with recombinant human albumin (rIX-FP), indicated for the treatment of hemophilia B, was approved by the Eur...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2510c4f61de49a51aba5dd5d4b7bf4cf
https://pubmed.ncbi.nlm.nih.gov/31469321

Zobrazit plný text záznamu

Akademický článek

Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII‐SingleChain and other common rFVIII products in Germany.

Autor: Olivieri, Martin¹ (AUTHOR), Sommerer, Patrick² (AUTHOR), Maro, Geraldine³ (AUTHOR), Yan, Songkai⁴ (AUTHOR) songkai.yan@cslbehring.com

Publikováno v: European Journal of Haematology. Apr2020, Vol. 104 Issue 4, p310-317. 8p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

RPM-1 is localized to distinct subcellular compartments and regulates axon length in GABAergic motor neurons.

Autor: Opperman, Karla J.¹ kopperma@scripps.edu, Grill, Brock¹ bgrill@scripps.edu

Publikováno v: Neural Development. 2014, Vol. 9 Issue 1, p1-29. 29p.

Zobrazit plný text záznamu

Akademický článek

Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis.

Autor: Hermans, Cedric, Marino, Renato, Lambert, Catherine, Mangles, Sarah, Sommerer, Patrick, Rives, Vincent, Maro, Geraldine, Malcangi, Giuseppe

Publikováno v: Advances in Therapy; Jun2020, Vol. 37 Issue 6, p2988-2998, 11p

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání